Sanofi: all 2,424 studies
Page 19 of 25. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial FunctionCompletedNCT00648453Phase 4
- Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell LymphomaCompletedNCT00644124Phase 1
- Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)CompletedNCT00642915Phase 4
- Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired PneumoniaCompletedNCT00638859Phase 3
- Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis MediaCompletedNCT00638534Phase 3
- Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal AllergenCompletedNCT00638118Phase 4
- A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsCompletedNCT00637884Phase 4
- Leflunomide in Systemic Lupus ErythematosusCompletedNCT00637819Phase 2
- Once Daily Given Alfuzosin in the Treatment of BPHCompletedNCT00637715Phase 4
- Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCompletedNCT00637611Phase 4
- Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineCompletedNCT00637585Phase 4
- Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCompletedNCT00637455Phase 4
- Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for DesloratadineCompletedNCT00636870Phase 4
- Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of GlimepirideCompletedNCT00633425Phase 4
- A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With OsteoporosisCompletedNCT00632216Phase 4
- Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in ToddlersCompletedNCT00631995Phase 1
- Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or LymphomaCompletedNCT00631579Phase 2
- Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaCompletedNCT00630175Phase 3
- Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic EtiologyCompletedNCT00629720Phase 3
- An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCompletedNCT00629551Phase 3
- Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)TerminatedNCT00627471Phase 4
- Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder CancerCompletedNCT00625664Phase 3
- Sepraspray™ Laparoscopic Myomectomy StudyCompletedNCT00624390Not applicable
- Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving EnoxaparinCompletedNCT00622648Phase 4
- Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)CompletedNCT00622115Phase 1
- To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentTerminatedNCT00620100Phase 2
- GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCompletedNCT00617968Phase 2
- Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid TherapyCompletedNCT00616694Phase 4
- Evaluation of the Effect of AVE0657 on Obstructive Sleep ApneaCompletedNCT00614250Phase 2
- Endometrial Cancer - LOHP Alone and With 5FUCompletedNCT00612495Phase 2
- Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNCT00611962Phase 2
- Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00611754Phase 2
- A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCompletedNCT00611507Phase 2
- The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning DosingCompletedNCT00609895Phase 4
- Rasburicase (Fasturtec) Registration TrialTerminatedNCT00607152Phase 3
- Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant SubjectsCompletedNCT00606359Phase 2
- Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses IntramuscularlyCompletedNCT00604058Phase 2
- Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based RegimensTerminatedNCT00603577Phase 3
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNCT00602745Phase 3
- Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's DiseaseTerminatedNCT00602680Phase 2
- PulmonarOM (Bacterial Lysates) in Respiratory Tract InfectionsCompletedNCT00599417Phase 4
- Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal MalesCompletedNCT00599001Phase 1
- Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCompletedNCT00596206Phase 3
- Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With PrevnarCompletedNCT00594347Phase 3
- Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial FibrillationTerminatedNCT00580216Phase 3
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesTerminatedNCT00577148Phase 3
- Extension to Study HMR1964A/3011 in BelgiumCompletedNCT00576862Phase 4
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesTerminatedNCT00576667Phase 3
- An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical PracticeCompletedNCT00576368Phase 4
- Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality StudyCompletedNCT00575913Phase 4
- Pompe Lactation Sub-RegistryCompletedNCT00566878
- Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin LesionsCompletedNCT00566657Phase 3
- Insulin Glargine, INITIATE Metabolic and Economic Outcomes of LantusCompletedNCT00565162Phase 4
- SSR240600C Treatment in Women With Overactive BladderCompletedNCT00564226Phase 2
- Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeCompletedNCT00564187Phase 4
- A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated MalariaCompletedNCT00563914Phase 1/2
- Leflunomide + Methotrexate in Rheumatoid ArthritisCompletedNCT00563849Phase 4
- Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis SyndromeCompletedNCT00563771Phase 4
- 20 Week Bridging Study in Type II DMCompletedNCT00563225Phase 3
- The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild HypertensionCompletedNCT00562809Phase 4
- Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)CompletedNCT00562172Phase 4
- Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With MicroalbuminuriaCompletedNCT00561964Phase 3
- Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00559455Phase 2
- Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial VaginosisCompletedNCT00556179Phase 4
- Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM VaccineCompletedNCT00554333Phase 3
- Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 DiabetesCompletedNCT00553020Phase 4
- Glycemic Optimization Treatment StudyCompletedNCT00552370Phase 4
- Satisfaction and Compliance of Risedronate in PMOCompletedNCT00549965Phase 4
- Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's LymphomaCompletedNCT00549185Phase 1
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCompletedNCT00549133Phase 4
- POWER Point of Care Effect on Satisfaction of TreatmentCompletedNCT00549068Phase 4
- Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.CompletedNCT00547768Phase 4
- Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerTerminatedNCT00547261Phase 1
- Glulisine + Lantus in Type I PatientsCompletedNCT00546702Phase 3
- Ketek in CAP / AECB in Ambulatory Adult PatientsCompletedNCT00546676Phase 4
- REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic AgentsCompletedNCT00546325Phase 3
- Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in AdultsCompletedNCT00545701Phase 2
- Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid ArthritisCompletedNCT00545454Phase 2
- Glulisine + Lantus in Type I PatientsCompletedNCT00545337Phase 3
- A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCompletedNCT00545246Phase 1
- ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a WeekTerminatedNCT00544180Phase 4
- Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid LeukemiaTerminatedNCT00543972Phase 1
- CARE Canadian ALS Riluzole EvaluationCompletedNCT00542412Phase 4
- Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate HypertrophyCompletedNCT00542165Phase 4
- The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate ScoreCompletedNCT00540891Phase 3
- PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+LisproCompletedNCT00540709Phase 4
- Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCompletedNCT00540410Phase 4
- A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast CancerCompletedNCT00540358Phase 2
- TAX + Carboplatin or Cisplatin 1st Line Post-Surgery OvarianCompletedNCT00539669Phase 2
- TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNCompletedNCT00539630Phase 3
- Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyCompletedNCT00539448Phase 4
- Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPDCompletedNCT00538148Phase 4
- Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance AreasCompletedNCT00538018Phase 4
- AMS VS MOXI Ketek vs Avelox in AMSCompletedNCT00537563Phase 3
- An Evaluation of the Efficacy and Safety of TOLAMBA™ for Ragweed-Allergic Rhinitis in an Environmental Exposure ChamberCompletedNCT00537355Phase 2
- 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes MellitusCompletedNCT00537251Phase 3
- An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety DisorderTerminatedNCT00535340Phase 3
- Venous Thromboembolism Taskforce Audit ProgramCompletedNCT00535171
- An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCompletedNCT00531622Phase 3
- Insomnia and Daytime Function in OsteoarthritisCompletedNCT00530556Phase 4